US grants full approval to Moderna’s COVID vaccine

WASHINGTON: The US Food and Drug Administration gave full approval to Moderna’s COVID-19 vaccine for people age 18 and older, making it the second fully approved vaccine for the virus. The Moderna vaccine has been authorised for emergency use in

Pakistan to receive 2.5mn Moderna vaccines from US

ISLAMABAD: The United States has announced to send 2.5 million doses of the Moderna vaccine to Pakistan. White House press secretary Jen Psaki said the doses of the Moderna COVID-19 vaccine are being sent to help Islamabad in the fight

Moderna starts COVID-19 vaccine trials for children

BOSTON: US manufacturer Moderna said it has started COVID-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants. The inoculation of children and young people is seen as critical

Iran bans import of US and UK-made COVID-19 vaccines

TEHRAN: Iran’s supreme leader banned the import of American and British-produced vaccines against Covid-19, saying they were “completely untrustworthy”. “Importing vaccines made in the US or the UK is prohibited,” Ayatollah Ali Khamenei said in a tweet. “It’s not unlikely

US approves Moderna as second COVID-19 vaccine

WASHINGTON: The United States has authorised Moderna’s COVID-19 vaccine for emergency use as the government struggles to quell the pandemic that is killing over 2,500 people a day in the country. US Food and Drug Administration (FDA) chief Stephen Hahn

US doubles spending on potential virus vaccine to $1 billion

WASHINGTON: The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by pharmaceutical company Moderna. The government now plans to spend up to $472 million on top of the previously announced

Biotech company Moderna says coronavirus vaccine is ready for trial

BOSTON: US biotech firm Moderna said it has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunisation. Moderna said in a statement that the first batch of its novel coronavirus